Cargando…

Melanin-Concentrating Hormone (MCH): Role in REM Sleep and Depression

The melanin-concentrating hormone (MCH) is a peptidergic neuromodulator synthesized by neurons of the lateral sector of the posterior hypothalamus and zona incerta. MCHergic neurons project throughout the central nervous system, including areas such as the dorsal (DR) and median (MR) raphe nuclei, w...

Descripción completa

Detalles Bibliográficos
Autores principales: Torterolo, Pablo, Scorza, Cecilia, Lagos, Patricia, Urbanavicius, Jessika, Benedetto, Luciana, Pascovich, Claudia, López-Hill, Ximena, Chase, Michael H., Monti, Jaime M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4681773/
https://www.ncbi.nlm.nih.gov/pubmed/26733789
http://dx.doi.org/10.3389/fnins.2015.00475
_version_ 1782405767844855808
author Torterolo, Pablo
Scorza, Cecilia
Lagos, Patricia
Urbanavicius, Jessika
Benedetto, Luciana
Pascovich, Claudia
López-Hill, Ximena
Chase, Michael H.
Monti, Jaime M.
author_facet Torterolo, Pablo
Scorza, Cecilia
Lagos, Patricia
Urbanavicius, Jessika
Benedetto, Luciana
Pascovich, Claudia
López-Hill, Ximena
Chase, Michael H.
Monti, Jaime M.
author_sort Torterolo, Pablo
collection PubMed
description The melanin-concentrating hormone (MCH) is a peptidergic neuromodulator synthesized by neurons of the lateral sector of the posterior hypothalamus and zona incerta. MCHergic neurons project throughout the central nervous system, including areas such as the dorsal (DR) and median (MR) raphe nuclei, which are involved in the control of sleep and mood. Major Depression (MD) is a prevalent psychiatric disease diagnosed on the basis of symptomatic criteria such as sadness or melancholia, guilt, irritability, and anhedonia. A short REM sleep latency (i.e., the interval between sleep onset and the first REM sleep period), as well as an increase in the duration of REM sleep and the density of rapid-eye movements during this state, are considered important biological markers of depression. The fact that the greatest firing rate of MCHergic neurons occurs during REM sleep and that optogenetic stimulation of these neurons induces sleep, tends to indicate that MCH plays a critical role in the generation and maintenance of sleep, especially REM sleep. In addition, the acute microinjection of MCH into the DR promotes REM sleep, while immunoneutralization of this peptide within the DR decreases the time spent in this state. Moreover, microinjections of MCH into either the DR or MR promote a depressive-like behavior. In the DR, this effect is prevented by the systemic administration of antidepressant drugs (either fluoxetine or nortriptyline) and blocked by the intra-DR microinjection of a specific MCH receptor antagonist. Using electrophysiological and microdialysis techniques we demonstrated also that MCH decreases the activity of serotonergic DR neurons. Therefore, there are substantive experimental data suggesting that the MCHergic system plays a role in the control of REM sleep and, in addition, in the pathophysiology of depression. Consequently, in the present report, we summarize and evaluate the current data and hypotheses related to the role of MCH in REM sleep and MD.
format Online
Article
Text
id pubmed-4681773
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-46817732016-01-05 Melanin-Concentrating Hormone (MCH): Role in REM Sleep and Depression Torterolo, Pablo Scorza, Cecilia Lagos, Patricia Urbanavicius, Jessika Benedetto, Luciana Pascovich, Claudia López-Hill, Ximena Chase, Michael H. Monti, Jaime M. Front Neurosci Endocrinology The melanin-concentrating hormone (MCH) is a peptidergic neuromodulator synthesized by neurons of the lateral sector of the posterior hypothalamus and zona incerta. MCHergic neurons project throughout the central nervous system, including areas such as the dorsal (DR) and median (MR) raphe nuclei, which are involved in the control of sleep and mood. Major Depression (MD) is a prevalent psychiatric disease diagnosed on the basis of symptomatic criteria such as sadness or melancholia, guilt, irritability, and anhedonia. A short REM sleep latency (i.e., the interval between sleep onset and the first REM sleep period), as well as an increase in the duration of REM sleep and the density of rapid-eye movements during this state, are considered important biological markers of depression. The fact that the greatest firing rate of MCHergic neurons occurs during REM sleep and that optogenetic stimulation of these neurons induces sleep, tends to indicate that MCH plays a critical role in the generation and maintenance of sleep, especially REM sleep. In addition, the acute microinjection of MCH into the DR promotes REM sleep, while immunoneutralization of this peptide within the DR decreases the time spent in this state. Moreover, microinjections of MCH into either the DR or MR promote a depressive-like behavior. In the DR, this effect is prevented by the systemic administration of antidepressant drugs (either fluoxetine or nortriptyline) and blocked by the intra-DR microinjection of a specific MCH receptor antagonist. Using electrophysiological and microdialysis techniques we demonstrated also that MCH decreases the activity of serotonergic DR neurons. Therefore, there are substantive experimental data suggesting that the MCHergic system plays a role in the control of REM sleep and, in addition, in the pathophysiology of depression. Consequently, in the present report, we summarize and evaluate the current data and hypotheses related to the role of MCH in REM sleep and MD. Frontiers Media S.A. 2015-12-17 /pmc/articles/PMC4681773/ /pubmed/26733789 http://dx.doi.org/10.3389/fnins.2015.00475 Text en Copyright © 2015 Torterolo, Scorza, Lagos, Urbanavicius, Benedetto, Pascovich, López-Hill, Chase and Monti. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Torterolo, Pablo
Scorza, Cecilia
Lagos, Patricia
Urbanavicius, Jessika
Benedetto, Luciana
Pascovich, Claudia
López-Hill, Ximena
Chase, Michael H.
Monti, Jaime M.
Melanin-Concentrating Hormone (MCH): Role in REM Sleep and Depression
title Melanin-Concentrating Hormone (MCH): Role in REM Sleep and Depression
title_full Melanin-Concentrating Hormone (MCH): Role in REM Sleep and Depression
title_fullStr Melanin-Concentrating Hormone (MCH): Role in REM Sleep and Depression
title_full_unstemmed Melanin-Concentrating Hormone (MCH): Role in REM Sleep and Depression
title_short Melanin-Concentrating Hormone (MCH): Role in REM Sleep and Depression
title_sort melanin-concentrating hormone (mch): role in rem sleep and depression
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4681773/
https://www.ncbi.nlm.nih.gov/pubmed/26733789
http://dx.doi.org/10.3389/fnins.2015.00475
work_keys_str_mv AT torterolopablo melaninconcentratinghormonemchroleinremsleepanddepression
AT scorzacecilia melaninconcentratinghormonemchroleinremsleepanddepression
AT lagospatricia melaninconcentratinghormonemchroleinremsleepanddepression
AT urbanaviciusjessika melaninconcentratinghormonemchroleinremsleepanddepression
AT benedettoluciana melaninconcentratinghormonemchroleinremsleepanddepression
AT pascovichclaudia melaninconcentratinghormonemchroleinremsleepanddepression
AT lopezhillximena melaninconcentratinghormonemchroleinremsleepanddepression
AT chasemichaelh melaninconcentratinghormonemchroleinremsleepanddepression
AT montijaimem melaninconcentratinghormonemchroleinremsleepanddepression